Metastatic bone disease: Pathogenesis and new strategies for treatment

Journal of Orthopaedic Science

Volumn 9, Issue 4, 2004, Pages 415-420

  Uchida, Atsumasa ^a   Wakabayashi, Hiroki ^a   Okuyama, Noritaka ^a   Okamura, Atsushi ^a   Matsumine, Akihiko ^a   Kusuzaki, Katsuyuki ^a  

^a MIE UNIVERSITY SCHOOL OF MEDICINE   (Japan)

Author keywords

Angiogenesis; Hyperthermia; Metastatic bone disease; Pathological fracture

Indexed keywords

CHONDROMODULIN I; FIBROBLAST GROWTH FACTOR 2; MATRIX METALLOPROTEINASE INHIBITOR; TRANSFORMING GROWTH FACTOR BETA; UNCLASSIFIED DRUG; VASCULOTROPIN;

ANGIOGENESIS; BONE METASTASIS; BONE PAIN; CANCER INVASION; CELL ADHESION; CELL MIGRATION; CELL MOTILITY; CELL PROLIFERATION; CONFERENCE PAPER; EXTRACELLULAR MATRIX; HYPERTHERMIC THERAPY; IMMOBILIZATION; NEUROLOGIC DISEASE; PATHOGENESIS; PATHOLOGIC FRACTURE; PROTEIN DEGRADATION; QUALITY OF LIFE;

EID: 4243141843     PISSN: 09492658     EISSN: None     Source Type: Journal    
DOI: 10.1007/s00776-004-0788-1     Document Type: Conference Paper

References (22)

1. Araki N, Myoui A, Kuratsu S, et al. Intraoperative extracorporeal autogenous irradiated bone grafts in tumor surgery. Clin Orthop 1999;368:196-206.
2. Chao EYS, Sim FH, Shives TC, et al. Management of pathologic fracture: biomechanical considerations. In: Sim FH, editor. Diagnosis and management of metastatic bone disease. New York: Raven Press; 1988. p. 171-81.
3. Folkman J, Watson KM, Ingber DE, et al. Induction of angiogenensis during the transition from hyperplasia to neoplasia. Nature 1989;315:115-22.
4. Frassica FJ, Sim FH. Pathogenesis and prognosis. In: Sim FH, editor. Diagnosis and management of metastatic bone disease. New York: Raven Press; 1988. p. 1-6.
5. Frassica FJ, Sim FH. Pathophysiology. In: Sim FH, editor. Diagnosis and management of metastatic bone disease. New York: Raven Press; 1988. p. 7-14.
6. Harrington KD, Sim FH, Enis JE, et al. Methylmethacrylate as an adjunct in internal fixation of pathological fracture: experience with three hundred and seventy-five case. J Bone Joint Surg Am 1976;58:1047-55.
7. Hioki Y, Seto M, Tomoda R, et al. Effects of biopsy on lung metastasis. Oncol Rep 2000;7:837-40.
8. Hiraki Y, Inoue K, Iyama K, et al. Identification of chondromodulin-I as a novel endothelial cell growth inhibitor. Purification and its localization in the vascular zone of epiphyseal cartilage. J Biol Chem 1997;272:32419-26.
9. Kusaka M, Takegami K, Sudo A, et al. Effect of hyperthermia by magnetic cement on tumor-induced bone destruction. J Orthop Sci 2002;7:354-7.
10. Morikawa J, Nishimura Y, Uchida A, et al. Molecular cloning novel mouse and human putative citrate lyase β-subunit. Biochem Biophys Res Commun 2001;289:1282-6.
11. Ribatti D, Vacca A, Dammacco F. The role of vascular phase in solid tumor growth: a historical review. Neoplasia 1999;1:293-302.
12. Sano T, Gabazza EC, Zhou H, et al. The zymogen prothrombin stimulates cell locomotion and calcium influx in murine osteosarcoma cells by different mechanism from thrombin. Int J Oncol 1999;15:1197-203.
13. Seftor REB, Seftor EA, Koshikawa N, et al. Cooperative interactions of laminin 5 gamma-2 chain, matrix mettalloproteinase-2, and membrane type 1 matrix/metalloproteinase are required for mimicry of embryonic vasculogenesis by aggressive melanoma. Cancer Res 2001;61:6322-7.
14. Seto M, Yamazaki T, Sonoda J, et al. Suppression of tumor growth and pulmonary metastasis in osteosarcoma using gene therapy. Oncol Rep 2002;9:337-40.
15. Takegami K, Sano T, Wakabayashi H, et al. New ferromagnetic bone cement for local hyperthermia. J Biomed Mater Res 1998;43:210-14.
16. Uchida A, Myoui A, Araki N, et al. Prosthetic reconstruction for periacetabular malignant tumors. Clin Orthop 1996;326:238-45.
17. Uchida A, Seto M, Hashimoto N, et al. Molecular diagnosis and gene therapy in musculoskeletal tumors. J Orthop Sci 2000;5:418-23.
18. Wakabayashi H, Hibasami H, Iida K, et al. Prevention of metastasis by a polyamine synthesis inhibitor in an animal bone metastasis model. Oncology 2000;59:75-80.
19. Yamada H, Tada-Oikawa S, Uchida A, et al. TRAIL causes cleavage of Bid by caspase-8 and loss of mitochondrial membrane potential resulting in apoptosis in BJAB cells. Biochem Biophys Res Commun 1999;265:130-3.
20. Yamashita Y, Hioki Y, Yamakawa T, et al. Antitumor effect by sustained release of tumor necrosis factor using porous ceramic delivery system. Bioceramics 1998;11:541-4.
21. Yoneda T, Sasaki A, Dunstan C, et al. Inhibition of osteolytic bone metastasis of breast cancer by combined treatment with the bisphosphonate ibandronate and tissue inhibitor of the matrix metalloproteinase-2. J Clin Invest 1997;99:2509-17.
22. Yoshikawa H, Ueda T, Kudawara I, et al. Surgical treatment for skeletal metastases from soft tissue sarcomas: experience with 23 lesions in 20 patients. Sarcoma 1998;2:107-14.